Segmental allergen challenge increases levels of airway follistatin-like 1 in patients with asthma.

[1]  M. Croft,et al.  Fstl1 Promotes Asthmatic Airway Remodeling by Inducing Oncostatin M , 2015, The Journal of Immunology.

[2]  Y. Geng,et al.  Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice , 2015, The Journal of experimental medicine.

[3]  B. Hostager,et al.  Follistatin-like protein 1 and its role in inflammation and inflammatory diseases , 2014, Immunologic research.

[4]  R. Kurten,et al.  Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages , 2013, Cellular microbiology.

[5]  E. Birgitte Lane,et al.  ‘See-saw’ expression of microRNA-198 and FSTL1 from a single transcript in wound healing , 2013, Nature.

[6]  M. Gavala,et al.  Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  M. V. D. van den Hoff,et al.  Follistatin-like 1 in vertebrate development. , 2013, Birth defects research. Part C, Embryo today : reviews.

[8]  Leif Oxburgh,et al.  FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expression. , 2012, Arthritis and rheumatism.

[9]  K. Ohmura,et al.  Follistatin‐related protein/follistatin‐like 1 evokes an innate immune response via CD14 and toll‐like receptor 4 , 2012, FEBS letters.

[10]  P. Friedman,et al.  Persistent airway inflammation and emphysema progression on CT scan in ex-smokers observed for 4 years. , 2011, Chest.

[11]  Ye Guang Chen,et al.  Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development , 2011, Proceedings of the National Academy of Sciences.

[12]  Xu Zhang,et al.  Follistatin-like 1 Suppresses Sensory Afferent Transmission by Activating Na+,K+-ATPase , 2011, Neuron.

[13]  David C. Wilson,et al.  Follistatin-Like Protein 1 Promotes Arthritis by Up-Regulating IFN-γ1 , 2009, The Journal of Immunology.

[14]  P. Ip,et al.  Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis. , 2009, Carcinogenesis.

[15]  E. Chiffoleau,et al.  An Immunomodulatory Role for Follistatin‐Like 1 in Heart Allograft Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  D. Broide.  Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. , 2008, The Journal of allergy and clinical immunology.

[17]  Leif Oxburgh,et al.  Developmental expression of mouse Follistatin-like 1 (Fstl1): Dynamic regulation during organogenesis of the kidney and lung. , 2007, Gene expression patterns : GEP.

[18]  R. Boudreau,et al.  Follistatin-Like Protein-1 Is a Novel Proinflammatory Molecule1 , 2006, The Journal of Immunology.

[19]  D. Broide,et al.  Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[20]  T. Mimori,et al.  Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. , 2004, Arthritis and rheumatism.

[21]  T. Mimori,et al.  Potential preventive effects of follistatin-related protein/TSC-36 on joint destruction and antagonistic modulation of its autoantibodies in rheumatoid arthritis. , 2003, International immunology.

[22]  R. Pauwels,et al.  Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. , 2002, The American journal of pathology.

[23]  W. Busse,et al.  Increased matrix metalloproteinase-9 in the airway after allergen challenge. , 2000, American journal of respiratory and critical care medicine.